IREN’s $4 Billion Revenue Target Has Wall Street Cheering, but a $836 Million Founder Pay Fight Won’t Go Quietly
Published on 07/23/2026 at 17:42 | Redaktion boerse-global.de
The numbers coming out of IREN are the kind that usually send a stock screaming higher. A raised annualized revenue forecast to $4 billion for 2026, up from a prior $3.7 billion target, with 85% of that already locked in by contract. A total contracted value with new clients of roughly $2.8 billion. Analyst Mike Colonnese at H.C. Wainwright responded by slapping a $90 price target and a Buy rating on the shares. The market took the cue: the stock surged 23.62% in seven days, adding another 4.38% on the latest session to trade at €37.63.
But beneath that rally runs a fault line that no amount of revenue guidance can paper over. The board and a vocal long-term shareholder are locked in a dispute over an equity compensation package for co-founders and co-CEOs Daniel Roberts and William Roberts worth roughly $836 million at the time of grant. And until that gets resolved, the stock’s recovery remains on shaky ground.
The Governance Clash That Won’t Fade
The board approved the restricted stock unit package on June 30, based on the June 29 closing price. On July 8, independent chairman David Bartholomew published an open letter defending the decision, arguing that the founders held only modest stakes compared with peers at other founder-led companies, that most of their prior equity grants were already vested or near vesting, and that the new tranches — representing about 3% of the company per CEO across the 2025 and 2026 allocations — can’t be sold until 2033. No further equity grants are planned until 2031.
The response from Epochal Corporation, an IREN shareholder since 2022, came on July 21 in the form of its own open letter. The Middle East-based investment firm demanded performance conditions on the unvested half of the package and called for an independent review — specifically, if 25% or more of votes cast against the compensation resolution, the board must commission a third-party audit within 90 days. No resolution has been reached.
Should investors sell immediately? Or is it worth buying IREN?
The timing couldn’t be more fraught. IREN is in the middle of a transformation from a Bitcoin miner into an AI infrastructure operator, a pivot that has already landed marquee clients like Nvidia and Microsoft and pushed the market cap from under $4 billion to over $16 billion. The company now targets 480 megawatts of capacity by year-end and 1.2 gigawatts by 2027. That buildout requires capital — and a lot of it.
The $21.1 Billion Funding Gap
Blocksbridge Consulting estimates that Bitcoin miners collectively need roughly $50 billion to fund their AI ambitions. IREN’s share of that funding gap is the largest in the sector at about $21.1 billion. Even with customer prepayments covering roughly 45% of related GPU investments, the capital requirement remains enormous. The company held $7.6 billion in liquid assets at the end of June, providing some cushion, but the scale of the expansion means equity-linked financing and convertible notes will almost certainly remain part of the equation.
That’s where the governance dispute becomes more than a distraction. A company that needs to keep its shareholders onside for future capital raises can’t afford a credibility gap on compensation — especially when the compensation in question has no fixed dollar value and no payout floor. The incentive structure only works if investors trust the board’s judgment on other capital-allocation decisions.
A Stock Caught Between Euphoria and Skepticism
The market’s split personality is visible in the price action. Over the past 12 months, IREN has climbed 182.76% from its 52-week low of €13.31. On a one-week basis, the stock is up 18.43%. But over the past month, it’s down 25.01%, and it still trades 45.15% below its 52-week high of €68.61 and 15.25% below its 50-day moving average. The 30-day annualized volatility sits at 95.50% — a number that captures just how sensitive the shares are to news in either direction.
The relative strength index at 48.4 suggests there’s room to run before the stock looks overbought. But the chart also tells a story of a stock that has yet to reclaim its prior trend. The gap between short-term momentum and medium-term weakness reflects the tug-of-war between operational optimism and governance anxiety.
IREN at a turning point? This analysis reveals what investors need to know now.
What Comes Next
For now, the operational story is winning. New contract wins continue to backstop the annualized revenue targets, and customer prepayments are reducing the company’s own financing burden. As long as that holds, the fundamental case should keep the stock supported.
But two things bear watching in the coming quarters: whether the board responds to Epochal’s demand for an independent review, and how the capacity buildout actually tracks against the 480-megawatt year-end target and the 1.2-gigawatt 2027 goal. The revenue forecast alone won’t determine whether this rally can reclaim the old highs. The execution of that buildout — and the resolution of the governance standoff — will.
Ad
IREN Stock: New Analysis - 23 July
Fresh IREN information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
